These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3305532)

  • 1. Micropreparative purification of recombinant human interleukin-2.
    Weir MP; Sparks J; Chaplin AM
    J Chromatogr; 1987 Jun; 396():209-15. PubMed ID: 3305532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and renaturation of recombinant human interleukin-2.
    Weir MP; Sparks J
    Biochem J; 1987 Jul; 245(1):85-91. PubMed ID: 3499142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and characterization of a recombinant murine interleukin-6. Isolation of N- and C-terminally truncated forms.
    Zhang JG; Moritz RL; Reid GE; Ward LD; Simpson RJ
    Eur J Biochem; 1992 Aug; 207(3):903-13. PubMed ID: 1499565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Separation by cation-exchange high-performance liquid chromatography of three forms of Chinese hamster ovary cell-derived recombinant human interleukin-2.
    Marchese E; Vita N; Maureaud T; Ferrara P
    J Chromatogr; 1990 Apr; 504(2):351-8. PubMed ID: 2341521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimized conditions for high-level expression and purification of recombinant human interleukin-2 in E. coli.
    Sengupta P; Meena K; Mukherjee R; Jain SK; Maithal K
    Indian J Biochem Biophys; 2008 Apr; 45(2):91-7. PubMed ID: 21086721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and characterization of recombinant human interleukin-2 produced in Escherichia coli.
    Kato K; Yamada T; Kawahara K; Onda H; Asano T; Sugino H; Kakinuma A
    Biochem Biophys Res Commun; 1985 Jul; 130(2):692-9. PubMed ID: 3896238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and renaturation of recombinant human lymphotoxin (tumour necrosis factor beta) expressed in Escherichia coli as inclusion bodies.
    Jin H; Uddin MS; Huang YL; Teo WK
    J Chem Technol Biotechnol; 1994 Jan; 59(1):67-72. PubMed ID: 7764497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preliminary study on the purification of IL-2].
    Yan Y; Hao Q; Fan GL; Zhao QW; Liu YW; Wang JL; Wan DL
    Se Pu; 2000 Jul; 18(4):325-7. PubMed ID: 12541508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recovery of bioactive protein from bacterial inclusion bodies using trifluoroethanol as solubilization agent.
    Upadhyay V; Singh A; Jha D; Singh A; Panda AK
    Microb Cell Fact; 2016 Jun; 15():100. PubMed ID: 27277580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromatographic purification of the C(H)2 domain of the monoclonal antibody MAK33.
    Thies MJ; Pirkl F
    J Chromatogr B Biomed Sci Appl; 2000 Jan; 737(1-2):63-9. PubMed ID: 10681042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renaturation, purification and characterization of streptokinase expressed as inclusion body in recombinant E. coli.
    Cherish Babu PV; Srinivas VK; Krishna Mohan V; Krishna E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jan; 861(2):218-26. PubMed ID: 17981102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-step purification and structural characterization of human interleukin-6 produced in Escherichia coli from a T7 RNA polymerase expression vector.
    Arcone R; Pucci P; Zappacosta F; Fontaine V; Malorni A; Marino G; Ciliberto G
    Eur J Biochem; 1991 Jun; 198(3):541-7. PubMed ID: 2050135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production and purification of refolded recombinant human IL-7 from inclusion bodies.
    Ouellette T; Destrau S; Ouellette T; Zhu J; Roach JM; Coffman JD; Hecht T; Lynch JE; Giardina SL
    Protein Expr Purif; 2003 Aug; 30(2):156-66. PubMed ID: 12880763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of clinical grade proteins produced by recombinant DNA technologies.
    Takacs BJ; Girard MF
    J Immunol Methods; 1991 Oct; 143(2):231-40. PubMed ID: 1940392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of soluble proteins from Escherichia coli.
    Wingfield PT
    Curr Protoc Protein Sci; 2005 Sep; Chapter 6():6.2.1-6.2.22. PubMed ID: 18429289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Purification and renaturation of recombinant human interleukin-2-pseudomonas exotoxin (IL2-PE66(4GLU)) fusion protein].
    Hu ZM; Linlai XM; Zhou MQ; Chen ZH; Wang XN
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Mar; 22(3):206-7. PubMed ID: 12390762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of ZetaPrep cartridge for the purification of human recombinant interleukin 1 beta.
    Casagli MC; Borri MG; D'Ettorre C; Galeotti CL; Di Liegro C; Ghiara P; Antoni G
    Prep Biochem; 1989; 19(1):23-35. PubMed ID: 2662172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification of human B cell growth factor.
    Mehta SR; Conrad D; Sandler R; Morgan J; Montagna R; Maizel AL
    J Immunol; 1985 Nov; 135(5):3298-302. PubMed ID: 3876383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rat interleukin 6: expression in recombinant Escherichia coli, purification and development of a novel ELISA.
    Rees GS; Ball C; Ward HL; Gee CK; Tarrant G; Mistry Y; Poole S; Bristow AF
    Cytokine; 1999 Feb; 11(2):95-103. PubMed ID: 10089129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and refolding of Escherichia coli-expressed recombinant human interleukin-2.
    Esfandiar S; Hashemi-Najafabadi S; Shojaosadati SA; Sarrafzadeh SA; Pourpak Z
    Biotechnol Appl Biochem; 2010 Apr; 55(4):209-14. PubMed ID: 20236092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.